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Abstract
Parasitic nematodes cause significant morbidity and mortality globally. Excretory/secretory
products (ESPs) such as fatty acid- and retinol- binding proteins (FARs) are hypothesized to
suppress host immunity during nematode infection, yet little is known about their interactions
with host tissues. Leveraging the insect parasitic nematode, Steinernema carpocapsae, we
describe here the first in vivo study demonstrating that FARs modulate animal immunity,
causing an increase in susceptibility to bacterial co-infection. Moreover, we show that FARs
dampen key components of the fly immune response including the phenoloxidase cascade
and antimicrobial peptide (AMP) production. Our data also reveal that FARs deplete lipid
signaling precursors in vivo as well as bind to these fatty acids in vitro, suggesting that FARs
elicit their immunomodulatory effects by altering the availability of lipid signaling molecules
necessary for an efficient immune response. Collectively, these data support a complex role
for FARs in immunosuppression in animals and provide detailed mechanistic insight into
parasitism in phylum Nematoda.

Author summary
A central aspect of parasitic nematode success is their ability to modify host biology,
including evasion and/or subversion of host immunity. Modulation of host biology and
the pathology caused by parasitic nematodes is largely effected through the release of proteins and small molecules. There are hundreds of proteins released by nematodes during
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Parasitic nematode FAR proteins compromise host immunity

an infection and few have been studied in detail. Fatty acid- and retinol-binding proteins
(FARs) are a unique protein family, found only in nematodes and some bacteria, and are
released during nematode infection. We report that nematode FARs from S. carpocapsae,
C. elegans and A. ceylanicum dampen fly immunity decreasing resistance to infection.
Mechanistically, this is achieved through modulation of the phenoloxidase cascade and
antimicrobial peptide production. Furthermore, FARs alter the availability of lipid
immune signaling precursors in vivo and show binding specificity in vitro.

Introduction
Helminths cause significant morbidity and mortality on a global scale through human disease,
sickening of livestock, and a reduction in crop yield [1,2]. Parasitic nematodes are responsible
for significant human suffering with a striking 1.5 billion people infected with soil-transmitted
helminths alone [3]. Much of the nematodes’ success in parasitism is due to their ability to disguise themselves from host immune defenses. Despite the importance of these organisms to
human and animal health, little is understood about the molecular mechanisms that underpin
these stealth processes. Increasing our understanding of immune modulation by parasitic
nematodes has the significant potential to inform treatment of such infections and lead to therapeutics for immune dysregulation such as autoimmune disorders.
Protein and small-molecule effectors are crucial for parasites to successfully infect plants,
invertebrates, and vertebrate hosts [4,5]. Upon infecting their hosts, nematodes release excretory/secretory products (ESPs) into surrounding tissues, which are the primary point of interaction between the parasite and host and are hypothesized to aid in nematode survival and
cause damage to the host. A variety of proteins are found in nematode ESPs, some of which
are known to cause tissue damage and modulate host immunity. One family of proteins
released by parasitic nematodes is the fatty acid- and retinol-binding protein family (FARs).
FARs are small (~20 kDa), alpha-helix rich, and may be responsible for sequestering essential
lipids required for reproduction and development [6]. FARs were first discovered in the filarial
nematode Onchocerca volvulus, the causative agent of river blindness. FARs have subsequently
been identified in the free-living nematode Caenorhabditis elegans as well as several other
nematode parasites of animals, plants and insects [7–9]. In C. elegans, FARs are localized in
the hypodermis, head and lips which are regularly in contact with the outside environment, as
well as the excretory cell connected to the hypodermis [10].
FARs have attracted attention because they were shown to be secreted by parasitic nematodes and are strongly immunogenic in infected hosts [8,11–13]. Moreover, several studies
suggested that FAR proteins modulate plant immunity. The strongest evidence comes from a
study on a FAR protein from the plant-parasitic nematode Meloidogyne javanica, which, when
expressed in planta, has been shown to increase the host susceptibility to further infection
[14]. FARs are released by infectious-stage parasites, and therefore several studies have suggested the importance of FARs in facilitating parasitism by sequestering host retinol and/or
fatty acids interfering with or suppressing immunity [15,16]. Previous research papers on FAR
proteins from animal-parasitic nematodes suggest that FARs modulate animal immunity, yet
no studies have investigated this experimentally. The functional role of these proteins in animal hosts as well as the mechanism of action behind these functions remains unknown.
One of the challenges to studying these host-parasite interactions is the paucity of studies in
model systems to develop testable hypotheses about effector function during infection. Using
an insect-parasitic nematode model allows studies to be conducted on large populations and
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some insect-parasitic nematode species are closely related to vertebrate-parasitic species, leading to insights that may be directly applicable to mammalian diseases [17,18]. Entomopathogenic nematodes (EPNs) are parasites of insects that are related to skin-penetrating nematodes
of mammals such as Strongyloides stercoralis [19–21]. Using the EPN Steinernema carpocapsae
as a model parasite and the fruit fly Drosophila melanogaster as a model host provides a robust
system to characterize potential effectors such as FARs. The fruit fly is a powerful genetic
model with a complex innate immune system containing mechanisms conserved in mammals
[22]. The D. melanogaster immune response has been a powerful model for mammalian
immunity and is divided into two innate response types; cellular and humoral immunity
[23,24]. Furthermore, immune responses are generally activated by two main NF-kB signaling
pathways, Toll and Imd, similar to human toll-like receptors (TLR) and tumor necrosis factor
(TNF) signaling respectively [23]. The Toll and Imd pathways are activated by different pathogens, depending on properties such as cell wall constituents. The cellular response is carried
out by hemocytes and involves processes that surround and kill the invading pathogen including phagocytosis and encapsulation, whereas the humoral response involves the generation of
antimicrobial peptides (AMPs) by the fat body, analogous to the mammalian liver and adipose
tissues. AMPs are small, cationic and often amphipathic peptides that function as endogenous
antimicrobials that “mop up” pathogens left over from the cellular immune defense system by
disrupting negatively charged microbial membranes. Systemic production of AMPs is controlled by the two NF-kB pathways, Toll and Imd [24]. A combinatorial response by the innate
immune system is likely elicited during a nematode infection [25].
In this study, we tested the hypothesis that nematode FAR proteins (Sc-FARs) can dampen
the animal immune response (D. melanogaster) in the context of various bacterial infections.
This work is the first to demonstrate that nematode FARs are detrimental to the outcome of
infection and are directly immunomodulatory in an animal system. Significant immune suppression by FARs was observed resulting in decreased host survival to bacterial infections,
accompanied by a significant increase in microbe growth. To understand how Sc-FARs modulate host immunity several readouts of Drosophila immunity were assessed including AMP
production and phenoloxidase activity. Potential FAR binding partners were assessed using
metabolomics and in vitro protein-metabolite interactions. In addition to demonstrating the
potent immunomodulatory effect of FARs in an animal, these data led us to propose a model
for nematode FAR modulation of host immunity.

Results
Genomic analysis of S. carpocapsae revealed an expansion of FAR proteins
Analysis of the genome sequence of the generalist insect-parasitic nematode S. carpocapsae
revealed an expansion of FARs compared to other nematodes [20]. We evaluated the presence
of FARs in a variety of parasitic nematodes and C. elegans and found a dynamic range of putative FAR-encoding genes among nematode genomes (Table 1). We found that S. carpocapsae
had the most with 45 putative FAR proteins, compared to 9 in C. elegans, 16 in S. stercoralis
and 5 in Ascaris lumbricoides (Table 1). While FARs are thought to be essential for lipid
sequestration, we found no putative FAR-encoding genes in either Trichinella spiralis or Trichiuris muris, suggesting that either these nematodes have divergent putative FAR genes that
were not recognizable by sequence similarity, or that they have evolved a different strategy to
acquire lipids from their hosts. Of the 45 putative FARs in S. carpocapsae, 5 FARs were found
in the ESPs of an in vitro infection model [26]. We chose the 2 found in highest abundance,
Sc-FAR-1 (L596_023208) and Sc-FAR-2 (L596_016036), for further study.
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Table 1. Number of putative FAR-encoding genes present in the genomes of various nematode species. Species in order from left to right: Steinernema carpocapsae
(Scar), Ancylostoma ceylanicum (Acey), Strongyloides stercoralis (Sste), Ascaris lumbricoides (Alum), Brugia malayi (Bmal), Caenorhabditis elegans (Cele), Dracunculus
medinensis (Dmed), Haemonchus contortus (Hcon), Onchocera volvulus (Ovol), Nippostrongylus brasiliensis (Nbra), Trichinella spiralis (Tspi), Trichiuris muris (Tmur). T
spiralis and T. muris have no known FAR encoding genes while S. carpocapsae shows the greatest expansion of FAR genes in its genome.
FAR encoding genes
Spp. Scar
# of genes 45

Acey

Sste

Alum

Bmal

Cele

Dmed

Hcon

Ovol

Nbra

Tspi

Tmur

24

16

5

3

9

3

11

3

12

0

0

https://doi.org/10.1371/journal.ppat.1010027.t001

Nematode FAR proteins modulate host immunity decreasing resistance to
bacterial pathogens
To investigate the immunomodulatory effects of FARs, we used D. melanogaster as a model
host and the two most abundant ESP-derived S. carpocapsae FARs Sc-FAR-1 and Sc-FAR-2,
hereafter referred to as FAR-1 and FAR-2, respectively. We tested D. melanogaster’s susceptibility to S. carpocapsae nematode infection but found that when flies are infected with any
number of infective juveniles IJs, they die quickly, and none are able to recover (S1 Fig). This
makes is difficult to observe immune modulation during an S. carpocapsae infection in flies.
Therefore, to measure immune modulation by FARs in flies, we utilized a bacterial infection
and first determined the LD30 dose of the Gram-positive, extracellular pathogen, Streptococcus
pneumoniae in OregonR flies and established the appropriate dose for injection and the baseline outcome of infections at this dose (S2 Fig). The outcome of infection was assessed using
fly survival and microbial growth over time. We found that the LD30 (the dose that kills 30% of
adult flies in the first 2–7 days post infection) is the optimal dose for injection, since it provides
sufficient sensitivity to detect shifts in the outcome of infection. Recombinant FAR-1 and
FAR-2 were co-injected into adult flies, mimicking an EPN infection with delivery of the protein and pathogenic bacteria into the hemocoel. These experiments revealed that a one-time
dose of FAR-1 and/or FAR-2 co-injected with the LD30 dose of S. pneumoniae significantly
affects the outcome of bacterial infection in flies. A dose-dependent effect was observed where
a high dose (250 ng) decreased host survival while lower doses did not elicit the same effect
(Fig 1A and 1B). We found no additive effects of FAR-1 and FAR-2 after co-injection (S3 Fig).
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Fig 1. Recombinant FARs reduced fly survival in a dose-dependent manner. A&B) 7,000 CFUs of S. pneumonia (Sp) were co-injected with various nanogram doses
of either Sc-FAR-1 or -2. C) CFUs were measured at 24 hours post-injection for panel B which shows a trend of increased bacterial growth with increasing protein doses.
All controls for survival curves (black) are Sp-injected only, without the addition of FAR proteins. Time 0 CFUs representative of all fly strains. Log-rank test p-value
significance indicated by asterisks on Kaplan Meier graphs. CFU graphs show p-value significance of an unpaired t-test (error bars show mean+SEM). Survival curves
n�180, CFU graph n�24. All raw data available in supplemental materials.
https://doi.org/10.1371/journal.ppat.1010027.g001
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We measured microbe growth over time for FAR-2 recombinant injections due to its dosedependent spread of effects on the outcome of survival. A trend in increased microbial load
was also observed, where the flies injected with the highest dose of FAR had a greater number
of bacterial cells 24-hours post-injection (Fig 1C). Heat-denatured recombinant FAR-1 or
FAR-2 was co-injected at the highest dose tested (250 ng); no difference was observed when
compared to S. pneumoniae-only injected flies, confirming that the addition of folded, recombinant FAR in a one-time dose alters the flies’ ability to deal with pathogenic infection (S4
Fig).
In addition to a one-time injection of recombinant of FAR-1 and FAR-2, we also determined the outcome of infection using transgenic flies expressing either FAR-1 or FAR-2. We
ectopically expressed these FARs in flies using the Gal4/UAS system and confirmed expression
with Western blot (S5 and S6 Figs). We also evaluated the effects of C. elegans-derived FAR-8
and a FAR from the human hookworm A. ceylanicum (S7 Fig). Flies expressing nematode
FAR proteins in the fat body, hemocytes, and salivary glands in the absence of bacterial infection are healthy and have a normal lifespan (S8 Fig). An expression-dependent decrease in survival in a bacterial infection model, was observed with strong, ubiquitous expression resulting
in the most severe decrease in survival. Expression of FARs only in the hemocytes had the least
severe effect on the outcome of infection (Fig 2A). The effect observed on survival is specific to
FAR-expressing flies since their genetic control did not elicit the same effect (S9 Fig). In addition, overexpression of mCherry, a protein irrelevant to the system, does not have any effect
on outcome of bacterial infection (S10 Fig). FAR-expressing flies also displayed a significant
increase in microbial load 24 hours post-injection (Fig 2B). To determine whether this effect
was pathogen-specific, the Gram-negative EPN symbiont Xenorhabdus innexi, one of the least
virulent bacteria in the genus, was also injected to induce an immune response [27]. Similar to
S. pneumoniae infection alone, flies expressing FAR-1 had a significant decrease in survival for
both doses, whereas FAR-2-expressing flies were only affected when injected with the higher
dose (Fig 2C). CFUs were also measured post-injection. A significant increase in microbial
load was observed in both FAR-1 & 2-expressing flies (Fig 2D). The intracellular Gram-positive pathogen Listeria monocytogenes was also tested. We found FAR expressing flies to have
the same decrease in survival, however there was no significant difference in microbe load 24
hours post-injection (Fig 2E and 2F). These data demonstrate that FARs significantly affect the
outcome of a bacterial infection, in a dose dependent manner, by decreasing survival post
infection and dampening the ability of the flies to control the bacterial growth over time. Interestingly, flies expressing C. elegans FAR-8 and a FAR from the human hookworm A. ceylanicum showed a similar immune deficient phenotype when challenged with an S. pneumoniae
infection (S7 Fig). This suggests that the immunomodulatory effects of FARs are conserved
across taxa, solidifying the value of this model for understanding the mechanism of FARs in
parasitic infection.

FARs dampen key aspects of immunity in D. melanogaster
D. melanogaster has a sophisticated, evolutionarily conserved, innate immune response that
can be categorized into two main branches: a systemic humoral response, and a cellular
response mainly carried out by various types of hemocytes (S11 Fig). To establish the mechanism by which FAR-1 and FAR-2 elicit their immunomodulatory effects, we evaluated several
readouts of immunity including phenoloxidase (PO) activity and melanization, which are
essential immune defenses during a bacterial infection. Disseminated melanization and PO
activity was measured post-injection with L. monocytogenes, which elicits a robust disseminated melanization phenotype 4 days post injection [28]. Flies expressing FAR-1 and FAR-2

PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1010027 October 29, 2021

5 / 24

PLOS PATHOGENS

A

Parasitic nematode FAR proteins compromise host immunity

B

Streptococcus pneumoniae

S. Pneumoniae 24 hour CFUs
*
*

He>+
He>FAR-1****
He>FAR-2****
CG>+
CG>FAR-1****
50

CG>FAR-2****
TubP>+
TubP>FAR-1****

0
0

5

10

15

TubP>FAR-2****

20

108

Log10 Bacteria CFUs / fly

Percent survival

100

He>+

107

He>FAR-1*

106

He>FAR-2*

105
104
103
102
101
0

Time (days)

24

Time (hours)

D

Xenorhabdus innexi

CG>+ 2.5x104

Percent survival

100

CG>FAR-1**
CG>FAR-2 ns
CG>+

50

5x104

CG>FAR-1***
CG>FAR-2****
0

0

10

20

30

Log10 Bacteria CFUs / fly

C

40

X. innexi 24 hour CFUs
109

106
105
104
103
102
0

CG>+

Percent survival

100

CG>FAR-1****
CG>FAR-2****
50

0

0

5

10

Time (days)

Log10 Bacteria CFUs / fly

F

Listeria monocytogenes

*

107

Time (days)

E

*

108

24

Time (hours)

CG>+ 2.5x104

CG>+ 5x104

FAR-1 2.5x104*

FAR-1 5x104*

FAR-2 2.5x104

FAR-2 5x104

L. monocytogenes 24 hour CFUs
106

CG>+
CG>FAR-1

105

CG>FAR-2
104
103
102
0

24

Time (hours)

Fig 2. Transgenic FAR expression significantly decreases fly survival and increases bacterial load 24-hours post-injection. Flies were injected with specified doses of
various pathogens. Survival was monitored daily and bacterial load was measured 24 hours post-injection. A&B) Flies FAR-1 & -2 expressed with a tubulin driver
(TubP), a fat body, hemocyte and lymph gland specific driver (CG), and a hemocyte only driver (He) were injected with 7,000 CFUs of Streptococcus pneumoniae.
Survival curves of flies are shown in (A) and bacterial CFUs in the He driver flies at 24-hour post injection in (B). C&D) Flies with FAR-1 & -2 expression with the CG
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driver were injected with 25,000 and 50,000 CFUs (shown at time 0) of Xenorhabdus innexi. Survival curves of flies are shown in (C) and bacterial CFUs in (D). E&F)
Flies with FAR-1 & -2 expression with the CG driver were injected with 1,000 CFUs of Listeria monocytogenes. Survival curves of flies are shown in (E) and bacterial
CFUs in (F). All controls are 86Fa flies crossed with flies containing the specified driver. Time 0 CFUs representative of all fly strains (depicted in black). Statistics shown
as log-rank test p-value for survival curves and unpaired t-test for microbe growth with (error bars show mean+SEM). Survival curves n�180, CFU graph n�24 over at
least 3 experiments. All raw data available in supplemental materials.
https://doi.org/10.1371/journal.ppat.1010027.g002

showed a significant decrease in survival when injected with ~1,000 CFUs of L. monocytogenes
(Fig 2E). After injection with 1,000 cells of L. monocytogenes, FAR-1 and FAR-2 expressing
flies were unable to initiate PO activity six hours post-infection (Fig 3A). Similarly, disseminated melanization, measured as two or more melanization spots throughout the body, was
reduced to only 20%, from 60% in controls, of the population in FAR-expressing flies 4 days
post-injection (Fig 3B). To further investigate the effect of FARs on innate immunity we
assessed their effect on the production of AMPs. We performed RT-qPCR to measure expression levels of two AMP-encoding genes: Defensin, mostly regulated by the Imd pathway, and
Drosomycin, mostly regulated by the Toll pathway [29]. After infection with S. pneumonia,
both FAR-1 and -2 expressing flies exhibit at least a 14-fold reduction in the AMP response for
both Drosomycin and Defensin (Fig 3C). Collectively, these data demonstrate that FARs
dampen key aspects of immunity.

FARs alter in vivo fatty acid availability including putative immune
signaling molecules
To determine the molecular mechanism underlying the immunomodulatory effects of FAR-1
and FAR-2, we initially screened for potential metabolites available to FAR using an
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Fig 3. Melanization, phenoloxidase and antimicrobial peptide activity was diminished in FAR expressing flies. A) Flies were injected with the LD30 of L.
monocytogenes (1,000 CFUs) and phenoloxidase activity was measured 6 hours post-injection. B) Flies were injected with the LD30 of L. monocytogenes and
disseminated melanization was observed 4 days post-injection. C) 24 hours post-injection with the LD30 dose of S. pneumoniae the relative increase in the antimicrobial
peptides (AMP) Drosomycin (Toll) and Defensin (Imd) were analyzed. Compared to the CG>+ control, FAR-1 and -2 significantly suppress both AMPs. Four
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experiments were repeated at least 3 times, error bars show mean+SEM. All raw data available in supplemental materials.
https://doi.org/10.1371/journal.ppat.1010027.g003
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Hemolymph targeted metabolites
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FAR-1 expressing flies. Statistics shown as an unpaired t-test and error bars show mean+SEM. Asterisk color for
significance matches sample color. All raw data available in supplemental materials.
https://doi.org/10.1371/journal.ppat.1010027.g004

untargeted metabolomics approach. We found many phosphatidylcholines (PC), phosphatidylethanolamines (PE), as well as multiple fatty acids that were less abundant in FAR-expressing flies, suggesting they are somehow depleted by FARs (S12 Fig). Since many of the
molecules that were significantly altered were unclassified, we moved to a targeted metabolomics approach. During an infection, FARs are released into the host tissue and may remain in
circulation to elicit their immunomodulatory effects. Therefore, we proceeded to test differences in lipid metabolite abundance in the hemolymph of the FAR-1- and FAR-2-expressing
flies, as well as control flies. Hemolymph was collected from 200 male flies and lipid concentrations between groups were assessed with targeted metabolomics. We found that several fatty
acid metabolites, some of which are epoxide derivatives of linoleic acid and leukotoxins in
mammals, were significantly lower in FAR-expressing flies when compared to the genetic control (Fig 4). These included linoleic acid, 9,10-EpOME, 9,10-DiHOME, 9-HODE, and
13-HODE. In addition to considerable overlap in lipid depletion, FAR-1 and FAR-2 affected
some lipids differently. For example, oleic acid and 12,13-EpOME were depleted in FAR1-expressing flies, but not FAR-2-expressing flies.

FARs have measurable differences in binding specificity in vitro
To determine potential binding partners of FARs, we measured the binding affinity to various fatty acids and retinol in vitro. Initially, we determined the binding affinity of both Sc
FARs to the 11-(Dansylamino) undecanoic acid (DAUDA), and retinol, by calculating the
equilibrium dissociation constant (Kd) (S10A and S10B, and S11A and S11B Figs). We
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Fig 5. In vitro binding of Sc-FARs. A&B) Competitive binding between 10-fold excess linoleic (LA), oleic, arachidonic
(AA) acid, and other fatty acids (all 10 μM) and DAUDA (1 μM) was tested in the context of FAR-1 & 2. Linoleic acid
displaces DAUDA the most, as seen by the largest reduction in relative fluorescence. Both 9(10)- and 12(13)-EpOME
displace DAUDA more easily in the presence of FAR-2, showing tighter binding. Statistics shown as One-way ANOVA
and error bars show mean+SEM. All raw data available in supplemental materials.
https://doi.org/10.1371/journal.ppat.1010027.g005

found the Kd to be in the 1–10 μM range (S13C and S13D, and S14C and S14D Figs). Using
DAUDA as the fluorophore, we tested various fatty acids in 10-fold excess in competition
with DAUDA to determine preferred fatty acid binding partners for FARs in vitro. When
FAR binds to a fatty acid in this assay, DAUDA is displaced from the protein resulting in a
reduction in peak fluorescence intensity (S13E and S13F Fig). Linoleic acid caused the
greatest displacement of DAUDA and 9(10)- and 12(13)-EpOME disrupted DAUDA
bound to FAR-2 greater than FAR-1 (Fig 5). The results indicated that FAR-1 & 2 have
measurable differences in binding specificity, suggesting that they may target different
lipid signaling molecules during infection.

Discussion
The results of this study provide the first evidence demonstrating that FARs alter the animal
immune response. Understanding how parasitic nematodes circumvent host immune
responses has significant potential to inform therapeutic intervention strategies. Much of what
is known about FAR proteins and their potential interactions with host immunity comes from
in vitro studies [30–34]. FARs initially attracted attention because they are excreted by parasitic
nematodes during an active infection and elicit a host immune response [8,11–13]. A previous
study has shown that FARs increase host susceptibility to nematode infections in plants however after performing S. carpocapsae nematode infections, we found that once a fly was
infected with even one nematode it was unable to recover from the infection and died quickly
[14]. This makes it especially difficult to determine variation in immune responses since the
infection is rapidly lethal at any dose. To investigate FAR’s effects on immunity we utilized
bacterial infections and found that the outcome of infections are significantly worse in flies
when FARs are present.
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FAR effects on innate immunity
We have investigated the specific aspects of immunity that are affected by FARs, and found
modulation of various mechanisms including phenoloxidase activity, a key mechanism to control invading parasites, and antimicrobial peptide production. Upon injury or infection,
insects rapidly initiate the melanization cascade leading to deposition of melanin along the
wounding site and around invading microbes or pathogens. This serves to block invading
pathogens, prevent excess hemolymph loss, and to encapsulate and kill pathogens with reactive
oxygen species (ROS) and other toxins. Melanization is independent of the classical immune
pathways (Toll & Imd). Rather, it is dependent upon activation of prophenoloxidase (proPO),
which is a proenzyme that is cleaved by prophenoloxidase activating enzyme (PPAE) to its
active form phenoloxidase (PO). Phenoloxidase is the catalyst for the oxidation of mono- and
diphenols to orthoquinones, which form polymers with melanin non-enzymatically, during
which ROS is produced [24,35]. Since the family of FAR proteins is highly conserved among
many nematode species it is important to understand whether FARs elicit their immunomodulatory effects in similar ways (Table 1) [35]. Slight differences between the effects of the two
Sc-FARs are apparent in flies challenged with X. innexi, where FAR-2 expressing flies given a
25,000 CFU dose did not do significantly worse than the control flies, as well as the recombinant studies and AMP production, pointing to a potential mechanistic specificity of FARs. We
performed additive recombinant FAR-1 and FAR-2 co-injections and found no difference
between a 250 ng dose of FAR-1 or FAR-2 and a 125 ng FAR-1 plus 125 ng FAR-2 combined
dose showing that FAR does not have an additive effect. FAR-1 and 2 seem to have similar in
vivo effects, at least at the level of the outcome of infection, leading us to believe that downstream immune effects are also being affected in similar ways not specific enough to evaluate
their differences. We found that even a one-time dose of recombinant FAR has severe adverse
effects on the outcomes of a bacterial infection. Flies generally exhibited a decrease in survival
in a dose-dependent manner, beginning with a 50 ng dose of FAR-1. During a bacterial infection the host is harmed by two factors: the pathogen and the immune response. In experiments
with FAR-2, low doses (20 ng and 50 ng) led to significantly improved survival, which we
hypothesize is due to the suppression of immune-induced damage. Although 250 ng is likely
greater than physiological concentrations of FAR during EPN infections, it is remarkable that
such a phenotype was observed with only a single component of a complex array of venom
proteins found in ESPs, where hundreds of proteins usually act in concert to dampen host
immunity. Interestingly, FARs not only modulate measurable outputs of immunity but affect
the outcome of infection.

Interactions of FARs and host lipid signaling pathways
A key component of understanding how nematodes utilize FARs to dampen host immunity is
to understand the mechanism underlying their interactions with immune molecules. We
hypothesize that FARs bind to lipids that function as signaling molecules for a diverse range of
functions including inflammation, immunity, homeostasis, and reproduction. It has been proposed that most terrestrial insects lack free long-chain polyunsaturated fatty acids (LC-PUFAs)
including arachidonic acid (AA), due to its role in oxidative stress [36,37]. Insects have high
levels of reactive oxygen species (ROS), such as the superoxide anion (O2-), due to their significant production of ATP in the mitochondrial electron transport chain. These ROS can escape
the mitochondria and often react with AA and other LC-PUFAs causing lipid peroxidation
leading to damaged cell membranes and possible adduct formation to proteins and nucleic
acids, giving rise to additional cell damage [36–38]. In mammals, free AA is released when
phospholipase A2 (PLA2) cleaves phospholipids directly from the membrane. In insects
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Fig 6. Key components of lipid biosynthesis in insects. Our hypothesis is that FAR is sequestering essential fatty acids and/or their upstream
lipids to disrupt lipid signaling that is necessary for certain host immune functions. We have shown FARs’ ability to bind to LA in vitro which could
temporarily disrupt downstream eicosanoid signaling. In insects, phospholipase A2 cleaves linoleic acid (LA) from the lipid bilayer instead of
arachidonic acid in mammals. Free LA is then extended via an elongase to a C20 fatty acid. Desaturase oxidizes the C20 to arachidonic acid which
can then be oxygenated to yield eicosanoid-like molecules. Eicosanoids are involved in many important functions including gene expression,
immune regulation and reproduction. Adapted [36].
https://doi.org/10.1371/journal.ppat.1010027.g006

however, PLA2 has been predicted to yield free linoleic acid (LA) which is then elongated to
AA and subsequently converted to downstream lipids such as prostaglandins and leukotrienes
that are essential signaling molecules in the immune response (Fig 6) [36,39]. Our untargeted
metabolomics study revealed that phosphatidylcholine (PC) and phosphatidylethanolamine
(PE) were reduced in FAR expressing flies (S12 Fig). These are essential phospholipids usually
incorporated into the cell membrane that give rise to many downstream lipids that could have
diverse functions including immune signaling and regulation [40]. We hypothesize that they
are depleted by a compensatory mechanism where more phospholipid is cleaved from the
membrane and converted to downstream fatty acids that are likely sequestered and depleted
more readily by FARs. Interestingly, our metabolite study of hemolymph shows a low but measurable concentration of AA, with much higher concentrations of C:18 fatty acids including
oleic and linoleic acids. These data support the hypothesis that in insects, LA is cleaved directly
from the lipid bilayer, providing evidence for the linoleic-to-arachidonic model of C20 biosynthesis in insects. Our data also show that FAR binds tightly to LA and not AA, in vitro. We
hypothesize that although LA is depleted by FARs, the depletion of downstream lipid products
such as 9-HODE and 13-HODE have a more significant effect on immune signaling. In mammals, pro- and anti- inflammatory lipids are produced from identical precursors with the
enzymes from each branch competing for substrate [41,42]. Therefore, the regulation of
enzyme availability decides the outcome of the immune response. Interestingly, PLA2 is turned
on by the Toll and Imd pathways in D. melanogaster and inhibited by the bacterial symbionts
of EPNs, Xenorhabdus and Photorhabdus (Fig 6) [27,40,43,44]. It is possible that in Drosophila
a similar network for substrate and enzyme availability takes place, however the identity of
pro- and anti-immune lipid signaling molecules is yet to be determined in this model.
Lipid signals have important roles in mammalian immunity and have been hypothesized to
play similar roles in insect immune defenses [45]. We found that S. carpocapsae FARs bind to
LA and oxidized metabolites of LA in vitro, which may suggest their preferred in vivo binding
partners. Our metabolomics studies showed that FARs deplete linoleic acid, oleic acid, 9(10)and 12(13)-EpOME, 9,(10)- and 12(13)- DiHOME, and 9- and 13-HODE from the blood of
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flies. These lipids are known to modulate diverse physiological functions in mammals and
have been shown to regulate immunity in insects [46]. 13-HODE has anti-inflammatory functions in mammalian immunity and is often increased under oxidative stress triggered during a
disease response, are depleted in the hemolymph of FAR expressing flies [47,48]. During a
mammalian immune response, 9(10)- and 12(13)-EpOME are activated by and interact with
inflammatory leukocytes or neutrophils [47]. These data support the hypothesis that FARs
modulate host immunity by binding to the oxidation products of LA or its upstream precursors to dampen the immune response (Fig 6). While little is known about how nematodes use
FARs and other ES molecules to interact with host immunity, model systems continue to be
invaluable in elucidating functional activity and yielding hypotheses that can be further tested.
In summary, this study shows experimentally that FAR-1 and FAR-2 from S. carpocapsae
dampen the host immune response and provides evidence that nematodes likely utilize other
ESPs in conjunction with FARs to modulate host immunity. These data lead us to hypothesize
that FARs act by disrupting lipid signaling necessary for immune responses. Deepening our
understanding of how nematode parasites evade or suppress host defenses is key to further our
development of treatment options for these infections, and may lead to the development of
novel treatments for autoimmune disorders.

Methods
Fly stock/maintenance
All fly strains were grown on D2 glucose medium from Archon Scientific (Durham, North
Carolina) and kept at 25˚C with 50% humidity on a 12h light 12h dark cycle.

Nematode Infection assays
Infection of OregonR and transgenic D. melanogaster adult flies with the infective juveniles of
S. carpocapsae was performed using the protocol published by Patrnogic et al., 2019. Briefly,
2–4-week-old IJs of S. carpocapsae collected from infected waxworms using White traps
(White, 1927), were used for the infection. Nematode infections were carried out at two densities, 100 worms/fly and 50 worms/fly. Nematodes were suspended in sterile distilled water
(250 μl) and added to vials containing four layers of filter papers (Whatman Grade 1, 20 mm).
250 μl of 1% sucrose was introduced to vials as the source of nutrients for the flies. 250 μl of
water plus 250 μl of 1% sucrose was used in uninfected controls. Ten anesthetized flies (five
males and females) were added to each vial. The vial flug was pushed down to restrict the
movement and increase the probability of infection. Vials were incubated at 25˚C. Infection
was set up in 6 vials for each nematode density and each fly type. Flies from 3 vials were dissected 24 h post-infection to quantify the nematode infection. Flies from 3 other vials were
transferred on food 24 h post-exposure to IJs and survival was monitored daily for 6 days.
Dead flies from each day were dissected to see determine successful nematode infection. On
the 6th day, all the flies were dissected to check for nematode infection. Infection experiments
were replicated three times.

Plasmid design and assembly
To assemble plasmid OA-1010, the base vector used for generating FAR protein-expressing
plasmids, several components were cloned into the piggyBac plasmid OA959C (Addgene
#104968) using Gibson assembly/EA cloning. Plasmid OA959C was digested with AvrII and
NotI, and the following components were cloned in with EA cloning: anattP sequence amplified from plasmid M{3xP3-RFP attP} with primers 1010.C1 and 1010.C2, a 10xUAS promoter
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fragment amplified with primers 1010.C3 and 1010.C4 from Addgene plasmid 78897, a p10
3’UTR fragment amplified from Addgene plasmid #100580 with primers 1010.C5 and 1010.
C6, and opie2-dsRed marker fragment amplified from Addgene plasmid #100580 using primers 1010.C7 and 1010.C8. The resulting plasmid was then digested with XhoI and PacI, and
the coding sequences (CDSs) of various FAR proteins that were codon-optimized for D. melanogaster expression and synthesized (GenScript, Piscataway, NJ) were separately cloned in to
generate the six final FAR protein-expressing vectors. Specifically, to generate vector OA1010Av2 (Addgene #176082), the codon optimized CDS of S. carpocapsae gene L596_g9608
was amplified with primers 1010.C9 and 1010.C10 from a gene-synthesized plasmid and
cloned into the above digested vector using EA cloning. Then, to generate vector OA-1010A
(Addgene #176078), OA-1010Av2 was digested with PacI and a G(4)S linker followed by a
30-amino-acid human influenza hemagglutinin (HA) epitope tag was amplified with primers
1010.C11 and 1010.C12 from the ninaE[SBP-His] vector and cloned into the above digested
vector using EA cloning. To generate vector OA-1010Bv2 (Addgene #176083), the codon optimized CDS of S. carpocapsae gene L596_g25050 were amplified with primers 1010.C13 and
1010.C14 from a gene-synthesized plasmid and cloned into the digested OA-1010 vector using
EA cloning. Then, to generate vector OA-1010B (Addgene #176079), OA-1010Bv2 was
digested with PacI and a G(4)S linker followed by a 30-amino-acid human influenza HA epitope tag was amplified with primers 1010.C15 and 1010.C12 from the ninaE[SBP-His] vector
and cloned into the above digested vector using EA cloning. To generate vector OA-1010C
(Addgene #176080), a fragment containing the codon optimized CDS of C. elegans gene far-8
followed by a G(4)S linker and a 30-amino-acid human influenza HA epitope tag was amplified with primers 1010.C16 and 1010.C12 from a gene-synthesized plasmid and cloned into
the XhoI/PacI-digested OA-1010 vector using EA cloning. To generate vector OA-1010D
(Addgene #176081), a fragment containing the codon optimized CDS of A. ceylanicum gene
Ac-far-1 (maker-ANCCEYDFT_Contig87-pred_gff_fgenesh-gene-3.1) followed by a G(4)S
linker and a 30-amino-acid human influenza HA epitope tag was amplified with primers 1010.
C17 and 1010.C12 from a gene-synthesized plasmid and cloned into the XhoI/PacI-digested
OA-1010 vector using EA cloning. All codon optimization was done by GenScript (Piscataway,
NJ) using OptimumGene algorithms.

Fly transgenesis
Transgenic flies were developed using codon optimized Sc-FAR-1 or Sc-FAR-2 inserted via
the PhiC31 site-specific serine integrase method. The transgenic UAS lines were then crossed
with several Gal4 drivers from the Bloomington Drosophila Stock Center (BDSC), including
TubP-Gal4 (#5138; strong, ubiquitous somatic expression), CG-Gal4 (#7011; expressed in the
fat body, hemocytes and lymph gland) and He-Gal4 (#8699; expressed in hemocytes). Fly husbandry and crosses were performed under standard conditions at 25˚C. Rainbow Transgenics
(Camarillo, CA) carried out all of the fly injections. All constructs were inserted into attP line
86Fa (BDSC #24486: y[1] M{vas-int.Dm}ZH-2A w[� ]; M{3xP3-RFP.attP’}ZH-86Fa).

Western blot
A modified version of the abcam general western blot protocol was used. 30 adult HA-tagged
transgenic flies were ground up in 200 μL lysis buffer and centrifuged at 20,000g for 20 minutes at 4˚C. The supernatant protein concentration was normalized to 1–2 mg/mL. 20 μL antiHA magnetic beads (Thermo Scientific 88836) were incubated with 150 μL of supernatant protein sample while shaking for 30 minutes. The sample was then removed, and the beads were
washed twice with 300 μL of TBST. The beads were then resuspended in 30 μL Tris-Cl pH 8.0
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and 10 μL loading buffer. The samples were heated for 10 minutes at 100˚C and electrophoresed on the SDS-PAGE gel. The proteins were transferred onto the immobilon PSQ (Millipore) for 1.5 hours at 50 Volts. The membrane was washed with PBS and blocked with 1%
BSA for 30 minutes with shaking. The membrane was washed twice with PBST for 10 minutes
and then incubated with HA-tag primary anti-rabbit antibody (Abcam ab236623) for 2 hours
with shaking. After incubation, the membrane was washed twice again with PBST for 10 minutes. Then anti-rabbit anti-goat antibody (Abcam ab6721) was added and incubated for 2
hours with shaking. Again, the membrane was washed twice with PBST and then developed
with Metal enhanced DAB substrate kit (Thermo Scientific 34065).

Bacterial stock maintenance
Streptococcus pneumoniae was grown by shaking in glass vials with 5 mL tryptic soy (TS) broth
(Difco TS broth, catalase, streptomycin) at 37˚C with 5% CO2 overnight. The overgrown culture was diluted in catalase (100 μL) and TS to yield a final volume of 20 mL in a flask and
incubated shaking until the OD600 ~ 0.4 (about 1 hour). The culture was then diluted again to
a final volume of 50 mL, with 150 μL catalase, and incubated until the OD600 ~ 0.2–0.4 (above
0.5 is no longer in log phase). 5% glycerol was added to the final culture and stored then in
1mL aliquots at -80˚C. To use the aliquots, one tube was thawed, spun down at 14,000 rpm for
5 minutes, the supernatant was removed, and the pellet was resuspended in the desired
amount of PBS (50–60 μL yields ~ 100,000 CFUs) and serially diluted to yield the appropriate
CFU doses. For quantification of CFUs, S.p. was plated on TSA agar plates supplemented with
50 mL/L sheep’s blood. Listeria monocytogenes (serotype 4b, 19115, (ATCC, VA)) was also
grown in batches in brain heart infusion (BHI) medium at 37˚C in aerobic condition. Cultures
were grown overnight in a flask inoculated with a fresh colony and rediluted under log phase
(below OD600 ~ 0.2) and grown up to the desired OD600 (~0.4). The entire volume was transferred to a 50mL centrifuge tube for vortexing. Before freezing, a 5% glycerol solution was
added to the culture and 1mL aliquots were stored at -80˚C. To use the aliquots, one tube was
thawed, spun down at 14,000 rpm for 5 minutes, the supernatant was removed, and the pellet
was resuspended in the desired amount of PBS (90–100 μL yields ~ 100,000 CFUs) and serially
diluted to yield the appropriate CFU doses. For quantification of CFUs, L.m. was plated on
BHI plates. Xenorhabdus innexi (HGB2121 attTn7/Tn7-GFP (from pURR25)) was incubated
at 27˚C shaking in Luria Bertani (LB) broth supplemented with 0.1% sodium pyruvate (sp).
Overnight cultures on X. innexi were subcultured below log phase (OD600< 0.4) and grown
back to log phase (OD600 0.4–0.8) and diluted to the desired concentrations before use, as well
as streaked on LB+sp plates bi-weekly for storage. LB+sp media was supplemented with 20%
glycerol for long term storage of log phase X. innexi in -80˚C.

Generation of recombinant proteins
The sequence corresponding to ScFARS-1 and ScFARS-2 was obtained from GenBank [49].
The sequences encoding the mature protein was codon-optimized, synthesized by GenScript
and cloned into a modified pET28 vector incorporating an N-terminal hexahistidine tag and a
TEV cleavage site. ScFARS-1 and ScFARS-2 were produced recombinantly in E. coli BL21-CodonPlus cells (Stratagene) grown in autoinduction medium (Invitrogen) from a 1% inoculum.
Following four hours of growth at 37˚C and 16 hours at 30˚C, the cells were harvested, and the
pellet resuspended in 20 mM Hepes pH 8.3, 1 M NaCl, 30 mM imidazole. Cells in suspension
were lysed using a French press, insoluble material was removed by centrifugation, and the soluble fraction was applied to a HisTRAP FF 5 mL column (GE Healthcare). Bound ScFARs1
and 2 were eluted with an increasing concentration of imidazole, the His tag was subsequently
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removed by TEV cleavage, and they were further purified by gel filtration chromatography on
a Superdex 200 16/60 HiLoad column in HBS (20 mM Hepes pH 7.5, 150 mM NaCl). The
purity of was assessed at each stage by SDS-PAGE.

Fly injections, survival and CFUs
For injections and immune assays, 5-7-day-old male flies were anesthetized with CO2 and
injected with various CFU doses yielding a total volume of 50 nL precisely using a MINJ-FLY
high-speed pneumatic injector (Tritech Research, CA) and individually pulled calibrated glass
needles. Flies were injected into the abdomen close to where the thorax meets and slightly ventral from the dorsal-ventral cuticle axis, easily visible below the haltere. Survival studies were
carried out for all of the pathogens we tested. After injection of the CFU dose or phosphate
buffered saline (PBS) control, flies were placed in vials in groups of 30 with a total of 60 flies
per experimental or control group. Flies injected with the human pathogens (S.p. and L.m.)
were kept at 28˚C with 50% humidity compared to flies injected with the insect pathogen X.i.
which was kept at 25˚C with 50% humidity. The number of dead flies was counted daily and
Kaplan-Meier survival curves were generated with GraphPad Prism software with statistics
shown as log-rank analysis (Mantel-Cox). Survival experiments were at least triplicated. CFUs
were determined by homogenizing a single infected, or buffer-injected fly in 200 μL of PBS,
serially diluted and plated on the appropriate agar plates and incubated overnight. Colonies
were counted the next day. At least five flies per condition were homogenized for CFU quantification each time an injection experiment was done to measure time 0 CFUs which are representative of all fly strains. All fly strains were injected at the same time for each experimental
replicate. Using GraphPad Prism software, results are shown as scatter plots with statistical significance analyzed using an unpaired t-test.

PO & disseminated melanization
Flies were injected with 1,000 CFUs of L. monocytogenes to elicit an immune induced melanization cascade. Phenoloxidase activity was measured as previously described [50, 51]. To collect hemolymph, 20–30 flies 4 hours post injection (p.i.) were pricked through the thorax and
placed in a pierced 0.5 μL Eppendorf tube and covered with glass beads, then placed inside a
1.5 μL Eppendorf tube containing 30 μL of 1x protease inhibitor cocktail (Fisher, PI78429).
Samples were centrifuged at 10,000 rpm for 20 minutes at 4˚C. Protein concentrations were
measured with Bradford assay (Bio-rad, 5000006) and then diluted in phosphate buffered
saline (PBS) to a concentration of 15 μg/uL and a total volume of 100 μL. Using a clear 96-well
plate, each well contained 160 μL L-Dopa (3 mg/mL) dissolved in phosphate buffer (37.5% 1
M potassium phosphate, 62.5% 1 M sodium phosphate, pH 6.5), 35 μL of hemolymph sample
and 5 μL CaCl2 (20 mM). PO activity was measured by kinetic reads at 29˚C at 492 nm every
minute for 60 min with 5 seconds of shaking between reads. The OD of a blank control was
subtracted from all biological values. Experiments were replicated five times with three technical replicates per experiment. Data were plotted as mean+SEM by taking the peak OD value
(timepoint ~ 30 min). Statistics shown as an unpaired t-test was done in GraphPad Prism. For
disseminated melanization, flies were observed for melanin deposits in the posterior and anterior abdomen, thorax, head and eyes four days p.i. with L.m. An individual was considered to
show disseminated melanization if it had two or more deposits of melanin, one often at the
wounding site and another either underneath the cuticle or in deeper tissues as previously
described [28]. Data were graphed as percent of the population infected that was melanized by
day four p.i. as the mean+SEM. Experiments were replicated three times with 40 individuals
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per experimental condition per experiment. Statistics shown as unpaired t-test was done in
GraphPad Prism.

Antimicrobial peptide gene expression—qPCR
Total RNA was extracted from 15 S. pneumonia infected flies per strain 24 hours post-injection
using Trizol reagent (Molecular Research Center, Inc; Cincinnati, Ohio) according to the
manufacturer instructions. Integrity of RNA was confirmed by observing bands on an agarose
gel and concentration was determined by nanodrop. Reverse transcription of RNA using ProtoScript II First Strand cDNA synthesis kit (New England BioLabs, NE, E6560L) following the
manufacturer protocol, in a MultiGene OptiMax Thermal Cycler (Labnet international, NJ).
The qRT-PCR was done with a CFX Connect Bio-Rad system with Perfecta SYBR green supermix (QuantaBio, MA) and gene specific primers for Defensin, Drosomycin, and Tubulin (Integrated DNA Technologies, IA). Experiments were carried out with three technical replicates
and repeated four times with plots shown as bar graphs with individual points representing
each replicate. Statistics shown as One-way ANOVA done in GraphPad Prism.

In vitro binding The fatty acid- and retinol- binding preferences of Sc-FAR in vitro was measured by utilizing
the saturated fatty acid fluorescent probe 11-(Dansylamino) undecanoic acid (DAUDA)
(Sigma-Aldrich, USA) and retinol as previously described [9,31]. Fluorescent emission spectra
for Sc-FAR bound to DAUDA (1 μM) and retinol (40 μM) were measured at 25˚C in a blackwalled 96-well plate yielding a total volume of 200 μL with an excitation wavelength of 345 nm
and 350 nm respectively. When DAUDA is encompassed by a binding protein a 50nm blue
shift is observed with an excitation wavelength of 345nm. The equilibrium dissociation constant (Kd) for Sc-FAR bound to DAUDA or retinol was estimated by adding increasing concentrations of Sc-FAR, in 1 or 2 μM increments, to 1 μM DAUDA in PBS and 40 μM retinol in
PBS. The data were normalized to the peak fluorescence intensity of DAUDA or retinol bound
to FAR (yielding a value of 1) and corrected for background fluorescence of PBS alone for each
concentration. The data were then plotted as relative fluorescence and a nonlinear fit via the
one site-specific system was used to find the Kd value in GraphPad Prism. Competition studies
were done by measuring the decrease in peak emission of DAUDA in the presence of another
fatty acid in 10-fold excess. Oleic, linoleic and arachidonic acid were tested along with 9,(10)and 12,(13)- EpOME and 13-HODE(Cayman Chemicals, MI). All competition experiments
were replicated 3 times with 3 technical replicates per experiment, plotted as bar graphs with
mean+SEM and individual points for each replicate, analyzed by an unpaired t-test. All fatty
acids and DAUDA were stored in -20˚C and freshly diluted before each experiment starting
with a working solution of either 10 or 100 μM in 100% ethanol and then subsequently diluted
in PBS to achieve the appropriate working solution.

Metabolomics
Whole fly untargeted -. Flies were transferred to a 2 mL bead mill tube and weighed, the
range was 131 mg to 302 mg. Ice-cold extraction solvent (20:20:30:30 water:IPA:ACN:MeOH)
was added, 3.32 μL/1 mg sample, and samples were homogenized in a liquid nitrogen cooled
bead mill, 6, 10 s cycles at 5 m/s. After centrifugation for 15 min at 16,000 x g at 4 C, the supernatant was analyzed by LC-MS. LC-MS metabolomics analysis was performed at the UC Riverside Metabolomics Core Facility as described previously [52]. Briefly, analysis was performed
on a Synapt G2-Si quadrupole time-of-flight mass spectrometer (Waters) coupled to an I-class
UPLC system (Waters). Separations were carried out on a CSH phenyl-hexyl column (2.1 x
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100 mm, 1.7 μM) (Waters). The mobile phases were (A) water with 0.1% formic acid and (B)
acetonitrile with 0.1% formic acid. The flow rate was 250 μL/min and the column was held at
40˚ C. The injection volume was 2 μL in positive ion mode and 4 μL in negative ion mode. The
gradient was as follows: 0 min, 1% B; 1 min, 1% B; 8 min, 40% B; 24 min, 100% B; 26.5 min,
100% B; 27 min, 1% B. The MS was operated in positive ion mode (50 to 1200 m/z) with a 100
ms scan time. MS/MS was acquired in data dependent fashion. Source and desolvation temperatures were 150˚C and 600˚C, respectively. Desolvation gas was set to 1100 L/hr and cone
gas to 150 L/hr. All gases were nitrogen except the collision gas, which was argon. Capillary
voltage was 1 kV in positive ion mode and 2 kV in negative ion mode. A quality control sample, generated by pooling equal aliquots of each sample, was analyzed every 4–6 injections to
monitor system stability and performance. Samples were analyzed in random order. Leucine
enkephalin was infused and used for mass correction. Untargeted data processing (peak picking, alignment, deconvolution, integration, normalization, and spectral matching) was performed in Progenesis Qi software (Nonlinear Dynamics). Data were normalized to total ion
abundance. To aid in the identification of features that belong to the same metabolite, features
were assigned a cluster ID using RAMClust [53]. An extension of the metabolomics standard
initiative guidelines was used to assign annotation level confidence [54,55]. Annotation level 1
indicates a match to an in-house library. Level 2a indicates an MS and MS/MS match to an
external database. Level 2b indicates an MS and MS/MS match to the Lipiblast in-silico database [56] or an MS match and diagnostic evidence, such as the dominant presence of an m/z
85 fragment ion for acylcarnitines. Level 3 indicates an MS and partial MS/MS match to an
external or in-house database. Several mass spectral metabolite databases were searched
against including Metlin, Mass Bank of North America, and an in-house database. Statistical
analyses were performed, and figures generated using R.
Hemolymph only (WashU) -. Hemolymph from 200 5-7-day old male flies was extracted
as previously described in [57]. Briefly, flies were pierced through the thorax with a tungsten
needle. Flies were placed in a pierced 0.5 mL Eppendorf tube within a 1.5 mL Eppendorf tube
containing 20μL of 10x protease inhibitor cocktail and centrifuged for two rounds of 10 minutes at 10,000 rpm at 4˚C with a gentle mixing in between rounds. The supernatant of the collected hemolymph was centrifuged for 10 minutes at 14,000 rpm to remove cells and debris.
The supernatant was flash-frozen in liquid nitrogen and stored at -80˚C until prepped for
metabolomics experiments.
Each of the pooled drosophila sample was initially homogenized with 260 μL of methanol
and 30 μL of water containing 2ng each of deuterated oxidative metabolites (9, 10-EpOME-d4,
12.13-EpOME-d4, 9, 10-DiHOME-d4, 12, 13-DiHOME-d4, 9-HODE-d4, and 13-HODE-d4) as
well as deuterated fatty acids (100ng; AA-d8 and 1000ng; linoleic acid (LA)-d4) as the internal
standards. Fatty acids as well as the internal standards were derivatized from 40 μL of the
homogenate with 50 mM DMAPA, 100mM EDC, and 100 mM DMAP. Four- to five-point
calibration standards of oxidative metabolites and fatty acids containing their deuterated internal standards were also prepared for the absolute quantification.
The sample analysis for the oxidative metabolites was performed with a Shimadzu 20AD
HPLC system coupled to a tandem mass spectrometer (API-6500+Qtrap: Applied Biosystems)
operated in MRM positive ion mode. For fatty acid analysis another Shimadzu 20AD HPLC
system coupled to the API-4000Qtrap mass spectrometer were used in MRM positive ion
mode. All samples were injected in duplicate for data averaging. Data processing was conducted with Analyst 1.6.3 (Applied Biosystems). Metabolomic analysis of fly hemolymph was
performed by the Metabolomics Facility of Washington University (St. Louis, MO).
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Statistics. All statistics were done with GraphPad Prism 8.4. Statistical significance indicated with asterisks indicating the following p-value cut offs: 0.05–0.033� , 0.033–0.002�� ,
0.002–0.0002��� and <0.0001���� .

Supporting information
S1 Fig. D. melanogaster has little to no survivability to S. carpocapsae infections. Flies were
exposed to a dose of 100 IJs/fly, using S.c. IJs. The survival rate equals the infection rate. Once
a fly is infected with even just one IJ it cannot survive the infection. Percent mortality overlaps
with percent infected. As with bacterial infections, various fly strains interact with infections
differently. Each line represents at least 90 flies.
(EPS)
S2 Fig. Dose response of various pathogens in wild-type OregonR flies was used to assess
virulence patterns and to identify the LD30, (dose that leads to 30% death of the population
within the first 1–5 days depending on the pathogen) an optimal dose to measure variations in immunity. 5-7-day-old male flies were used for all injections with phosphate buffered
saline (PBS) shown as the vehicle control. A) 100 to 100,000 CFUs of Streptococcus pneumoniae were injected, LD30 identified as 7,000 cells. B) 10 to 100,000 cells of Listeria monocytogenes were injected, LD30 identified as 1,000 cells. C) 100 to 100,000 cells of the insect
pathogen Xenorhabdus innexi were injected, 25,000 and 50,000 cell doses were chosen for
study. All raw data available in supplemental materials.
(EPS)
S3 Fig. We performed additive recombinant FAR-1 and FAR-2 injection experiments with
the LD30 of S. pneumoniae and found no difference between a 250 ng dose of FAR-1 or
FAR-2 and a 125 ng FAR-1 plus 125 ng FAR-2 combined dose showing that FAR does not
have an additive effect. The graph below shows at least 180 flies per line with statistical significance shown as a log-rank test.
(EPS)
S4 Fig. Recombinant FAR elicits a specific effect on the outcome of a bacterial infection.
As a control to validate the effects of recombinant FAR proteins on immunity, denatured S.
carpocasae FARs were co-injected with 7,000 CFUs of S. pneumoniae. A) Denatured Sc-FAR-1
(250ng) co-injected with S.p. shows no significant difference from S.p.-only injected flies. B)
Denatured Sc-FAR-2 (250ng) co-injected with S.p. shows no significant difference from S.p.only injected flies. Statistics shown as Log-rank test. All raw data available in supplemental
materials. Experiments not found to be significantly different from bacteria-only controls were
marked ns.
(EPS)
S5 Fig. Overview of the UAS-Gal4 genetic crosses of FAR expressing and control flies. The
sequence of FAR-1 or -2 was inserted into the 86Fa fly strain which displays a fluorescent red
body and eye color and crossed with various Gal4 promoter strains. As a control, the 86Fa fly
was crossed with the Gal4 driver flies as well as the FAR-1 or -2 transgenic flies were crossed
with a w1118 strain. The male flies yielding the appropriate genotypes were tested for their
immunodeficiencies after inducting an immune response with a bacterial injection into the
abdomen.
(EPS)
S6 Fig. Western blot shows in vivo production of FAR proteins. FAR is expressed when
driven with the Gal4 driver in the first 4 wells (rows 1–4). Control flies not expressed with
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UAS-Gal4 expression system do not show the presence of FAR proteins (rows 5–8).
(EPS)
S7 Fig. FAR proteins from other species of nematodes show similar negative effects on the
outcome of a S. pneumoniae infection. Flies expressing FAR-8 from the free-living nematode
Caenorhabditis elegans or a FAR from the mammalian hookworm Ancylostoma ceylanicum
(maker-ANCCEYDFT_Contig87-pred_gff_fgenesh-gene-3.1) with the CG driver had a significant decrease in survival after injected with 7,000 cells of S.p. Statistics shown as Log-rank
test. All raw data available in supplemental materials.
(EPS)
S8 Fig. Lifespan of FAR transgenic flies expressed with the fat-body and hemocytes specific
driver CG. Lifespan is not altered within the timeframe where immunity studies took place
(day 0 to 20). Statistics shown as Log-rank test. All raw data available in supplemental materials.
(EPS)
S9 Fig. Genetic control of 86Fa transgenic strains. As a control to validate the specific effects
on immunity after promoting the FAR transgenics, FAR-1 & -2 expressing flies were crossed
with w1118 flies. There was no significant difference observed between all genotypes validating
the specific effects of FAR. All raw data available in supplemental materials.
(EPS)
S10 Fig. When mCherry is overexpressed by the CG-Gal4 driver, there is no significant
reduction in survival as compared to control crosses. All lines represent at least 180 flies.
(EPS)
S11 Fig. Simplified overview of Drosophila immunity. Detection of pathogens elicits an
array of interconnected innate immune responses specifically divided into the humoral, or systemic, and the cellular response. Humoral immunity leads to the production of antimicrobial
peptides (AMPs) downstream of either the Toll or Imd pathways. Cellular immunity is carried
out by different types of hemocytes that surround and kill invading microbes. Adapted from
[24,58].
(EPS)
S12 Fig. Volcano plot comparing relative abundance of metabolites in CG>FAR-1 expressing and CG>+ control flies. Phosphatidylcholines (PC), phosphatidylethanolamines (PE)
and multiple fatty acids were found to be more abundant in control flies, meaning they are
depleted in FAR expressing flies as well as potential binding partners, or upstream compounds
of FARs binding partners. All raw data available in supplemental materials. LC-MS analysis
depicted in this figure was performed at the UC Riverside Metabolomics Core Facility.
(EPS)
S13 Fig. In vitro binding properties of S. carpocapsae FARs to fatty acids. A&B) Plots of
increasing concentration of FAR binding to 1μM 11-(Dansylamino) undecanoic acid
(DAUDA) in PBS reveal a Kd in the 10 μM range. Kd was estimated by using the best-fit in
Graphpad Prism. C&D) When DAUDA is bound to FAR (13 μM) in vitro, a ~50nm blue shift
is observed in the peak. E&F) Full curve of in vitro competition assays shows a decrease in fluorescence when linoleic acid (10 μM) binds to and therefore displaces DAUDA (1 μM) from the
fatty-acid binding pocket of FAR. All raw data available in supplemental materials.
(EPS)
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S14 Fig. In vitro binding properties of S. carpocapsae FARs to retinol. A&B) Plots of
increasing concentration of Sc-FAR binding to 40μM retinol in PBS reveal a Kd in the 1 μM
range. Kd was estimated by using the best-fit in Graphpad Prism. C&D) When retinol is
bound to FAR (5 μM) in vitro, the peak fluorescence is greatly increased. All raw data available
in supplemental materials.
(EPS)
S15 Fig. FARs’ role in increased mortality and microbe load is not limited to the LD30
dose. FAR-1 and -2 were expressed with the CG driver and injected with 100 to 100,000 CFUs
of S.p. A&C) Survival was measured daily showing that FARs significantly increase mortality
rate in most doses. B&D) In the presence of FAR, various doses of S.p. also cause an increase
in microbe growth 24 hours p.i. Dotted lines show CG>+ and solid lines show CG>FAR-1 or
-2. Statistics shown as Log-rank tests for survival curves and unpaired t-tests for microbe
growth. All raw data available in supplemental materials.
(EPS)
S1 Data. Excel file contains all the raw data used in this research study. The data used for
each figure is included on a separate tab, organized by figure number.
(XLSX)
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